- Accueil
- 98 054 508 ds
- G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
5 (296) · € 29.99 · En Stock
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach
PDF] GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment
Full article: GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)
GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
Activation and signaling mechanism revealed by GPR119-Gs complex structures
A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression - ScienceDirect
Regulation of GPR119 receptor activity with endocannabinoid-like lipids
GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy, Journal of Experimental & Clinical Cancer Research
